NTP Bundle

For general laboratory use.
Please centrifuge briefly before opening (volume ≤2 ml).
Description:
NTP Bundle contains four separate solutions of ultrapure ATP, CTP, GTP and UTP supplied as clear aqueous solutions (pH 8.0).
ATP (#NU-1010)
CTP (#NU-1011)
GTP (#NU-1012)
UTP (#NU-1013)
Shipping: shipped on gel packs
Storage Conditions: store at -20 °C
Shelf Life: 12 months after date of delivery
Molecular Formula:
ATP: C10H16N5O13P3 (free acid)
CTP: C9H16N3O14P3 (free acid)
GTP: C10H16N5O14P3 (free acid)
UTP: C9H15N2O15P3 (free acid)
Molecular Weight:
ATP: 507.18 g/mol (free acid)
CTP: 483.16 g/mol (free acid)
GTP: 523.18 g/mol (free acid)
UTP: 484.14 g/mol (free acid)
Purity: ≥ 99 % (HPLC)
Form: clear aqueous solution
Concentration: 100 mM ±2 %
pH: 8.0 ±0.2 (22 °C)
Spectroscopic Properties: ATP: λmax 259 nm, ε 15.1 L mmol-1 cm-1 (Tris-HCl pH 7.0) CTP: λmax 271 nm, ε 8.9 L mmol-1 cm-1 (Tris-HCl pH 7.0) GTP: λmax 252 nm, ε 14.2 L mmol-1 cm-1 (Tris-HCl pH 7.0) UTP: λmax 262 nm, ε 9.8 L mmol-1 cm-1 (Tris-HCl pH 7.0)
Quality Control Specifications:
in vitro transcription: suitable
contamination with bacterial and human DNA: not detectable
activity of DNase
| Cat. No. | Amount | Price |
|---|---|---|
| NU-1014S | 4 x 200 μl (4 x 20 μmol) | 44,80 € |
| NU-1014L | 4 x 1 ml (4 x 100 μmol) | 178,60 € |
At this point, external content from bioz.com is embedded. When it loads, data (e.g. your IP address) is transmitted to the provider.
Scientific citations for Jena Bioscience nu-1014
26 scientific citations and 7 citation images found by Bioz.
-
Structural basis for multi-subunit DNA-dependent RNA polymerase catalytic activity
Molecular cell, 2026-05-21 · PMID:42066755
.. , Anatrace , Cat#F300F.fluorinated fos-choline-8 (FC8F); (1H, 1H, 2H, 2H-Perfluorooctyl)phosphocholine , Anatrace , Cat#F300F.. Nucleotide triphosphates (ATP, GTP, UTP,
CTP ) ,Jena Biosciences , Cat#NU-1014 .. 3’-deoxy GTP (3’-Deoxyguanosine-5’-triphosphate) , Jena Biosciences , Cat#NU-1145.3’-deoxy GTP (3’-Deoxyguanosine-5’-triphosphate) , Jena Biosciences , .. -
mRNA-based SARS-CoV-2 vaccines: intracellular processing and aggregation of the encoded spike protein as a mechanistic contributor to cardiac cellular stress.
Frontiers in Immunology, 2026-03-09 · PMID:41798954
The in vitro transcription reaction (40 mM Tris-HCl, 10 mM DTT, 2 mM spermidine, 0.002% Triton X-100, 16.5 mM magnesium acetate, 4 mM CleanCap AG, 5 mM ATP, CTP,
GTP (# ), N1-methylpseudo-UTP (#NU-890L,NU-1014 LJena Bioscience GmbH , Germany), 0.0002 U/μl inorganic pyrophosphatase (#EF0221, Thermo Fisher Scientific Inc., USA), 1 U/μl RNasin RNase inhibitor (N2511, Promega Corp., USA), 50 μg/ml DNA template, 8 U/μl T7 RNA polymerase (#EP0113, .. -
Lipid nanoparticle-based non-viral in situ gene editing of congenital ichthyosis-causing mutations in human skin models.
Cell Stem Cell, 2026-02-06 · PMID:41605220
Abstract: Autosomal recessive congenital ichthyosis (ARCI) refers to a group of rare, highly debilitating skin disorders that significantly impair patients' quality of life and lack any effective treatment options. Here, we report clinically relevant in situ correction of the most common ARCI-causing mutation, TGM1 c.877-2A>G, a splice-site aberration, in human disease models. Targeted skin barrier modulation followed by topical application of the cytosine base editor eTd packaged into lipid nanoparticles yielded functional restoration of ∼30% of wild-type transglutaminase 1 activity in skin tissue